FDA Enforcement Class II Terminated

Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBSIs compared to the original ARROWg+ard Blue catheter has not been studied

Recall: Z-1879-2017 · Reported May 3, 2017

Enforcement

Recall Number
Z-1879-2017
Event ID
76935
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Arrow International Inc
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
May 3, 2017
Initiation Date
March 17, 2017
Classification Date
April 26, 2017
Termination Date
March 24, 2020
Address
2400 Bernville Rd, N/A, Reading, PA, 19605-9607, United States

Description

Pressure Injectable Arrowg+ard Blue Plus Multi-Lumen Central Venous Catheterization Kit. Permits venous access to central circulation by way of subclavian, jugular and femoral veins. The ARROWg+ard technology is intended to provide protection against catheter-related bloodstream infections (CRBSIs). It is not intended to be used as a treatment for existing infections nor is it indicated for long-term use (>30 days). Clinical effectiveness of the ARROW g+ard Blue Plus catheter in preventing CRBSIs compared to the original ARROWg+ard Blue catheter has not been studied

Reason

Arrow International is recalling due to possible voids in the catheter hub, which could lead to an interlumen crossover.

Code Info

Product Codes ASK-45703-PRWJ1, ASK-45703-PUAB1, and ASK-45703-PUPM Lot # 13F16L0105, 23F16K0180 and 13F16L0199

Distribution

US Distribution to NJ, IL, and PA

Quantity

310 units